爱尔眼科关联医院涉医保违规，股价短期承压，市场关注治理风险

Core Viewpoint - The exposure of Xiangyang Hengtai Kang Hospital and other mental health institutions for allegedly fabricating treatment projects and misappropriating medical insurance funds has raised concerns about governance risks associated with Aier Eye Hospital, despite the company's claim that the involved hospital is not part of its listed company system [1] Stock Performance - Following the incident, Aier Eye Hospital's stock price dropped by 3.82% on February 6, closing at 11.07 yuan, and further declined to 10.33 yuan by February 13, marking a cumulative decrease of approximately 10.3% from the pre-incident closing price of 11.51 yuan on February 5 [2] - On February 13, there was a net outflow of 363 million yuan in main capital, with a significant increase in cumulative net outflow over the past five days, indicating a cautious market sentiment [2] Company Status - Although the involved hospital is not included in the listed company's financial statements, it shares a common actual controller (Chen Bang) with Aier Eye Hospital, and the chairman of the involved hospital, Zhang Yuwen, also serves as the party secretary of Aier Eye Hospital and president of Aier Medical Investment Group, highlighting governance connections [3] - Historical violations include at least 10 companies associated with Aier Eye Hospital that have faced penalties for medical insurance violations such as itemized billing and duplicate charges, indicating that compliance issues with related parties are not isolated incidents [3] Company Fundamentals - The company's net profit attributable to shareholders decreased by 9.76% year-on-year in the first three quarters of 2025, with the gross profit margin falling to 49.27%, partly due to increased depreciation and amortization from new hospital openings [4] - Aier Eye Hospital continues to advance its "1+8+N" graded chain network strategy, but the complexity of management has increased due to rapid expansion, and this incident may intensify market skepticism regarding its cross-system management capabilities [4] Event Impact - The incident has created short-term pressure on Aier Eye Hospital's stock price and capital flow, primarily reflecting market concerns about the risk transmission from non-listed company systems to the listed platform [5] - In the medium to long term, attention should be paid to improvements in corporate governance transparency and the progress of compliance rectification for related businesses [5]